The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The mammalian prokineticins family comprises two conserved proteins, EG-VEGF/PROK1 and Bv8/PROK2, and their two highly related G protein-coupled receptors, PKR1 and PKR2. This signaling system has been linked to several important biological functions, including gastrointestinal tract motility, regulation of circadian rhythms, neurogenesis, angiogenesis and cancer progression, hematopoiesis, and nociception. Mutations in PKR2 or Bv8/PROK2 have been associated with Kallmann syndrome, a developmental disorder characterized by defective olfactory bulb neurogenesis, impaired development of gonadotropin-releasing hormone neurons, and infertility. Also, Bv8/PROK2 is strongly upregulated in neutrophils and other inflammatory cells in response to granulocyte-colony stimulating factor or other myeloid growth factors and functions as a pronociceptive mediator in inflamed tissues as well as a regulator of myeloid cell-dependent tumor angiogenesis. Bv8/PROK2 has been also implicated in neuropathic pain. Anti-Bv8/PROK2 antibodies or small molecule PKR inhibitors ameliorate pain arising from tissue injury and inhibit angiogenesis and inflammation associated with tumors or some autoimmune disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Costigan, M., Scholz, J., & Woolf, C. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135531 · Cited by 2,025 · cited 1×
“It is associated with neuroinflammation-related events that participate in pain generation and chronicization (48, 79).”
BackgroundA cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · cited 1×
“Also, much recent evidence supports the notion that various bone marrow-derived cell types regulate tumor angiogenesis and growth by a variety of mechanisms that are often context-dependent (10, 50, 137, 140).”
BackgroundIL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608 · cited 1×
“A similar Cys motif is also present in mammalian colipase [called a colipase fold, as already noted (17)] and in the COOH-terminal region of members of the Dickkopf family of extracellular signaling proteins that organize head development in embryos (85).”
BackgroundExperimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Boehm, U., Bouloux, P.-M., Dattani, M. T., de Roux, N., Dodé, C., Dunkel, L., Dwyer, A. A., Giacobini, P., Hardelin, J.-P., Juul, A., et al. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.112 · Cited by 874
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
Self-citationProkineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus
Cheng, M. Y., Bullock, C. M., Li, C., Lee, A. G., Bermak, J. C., Belluzzi, J., Weaver, D. R., Leslie, F. M., & Zhou, Q.-Y. (2002) · Nature · doi:10.1038/417405a · Cited by 715 · cited 10×
“PKR2 is expressed in essentially all the primary SCN target sites, including the lateral septum (LS), paraventricular talamic nucleus (PVT), paraventricular nucleus (PVN), and dorsomedial hypothalamic nucleus (DMH) (35, 37).”
BackgroundInfluentialKowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015855107 · Cited by 663
Self-citationKallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2
Dodé, C., Teixeira, L., Levilliers, J., Fouveaut, C., Bouchard, P., Kottler, M.-L., Lespinasse, J., Lienhardt-Roussie, A., Mathieu, M., Moerman, A., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020175 · Cited by 457
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
Chung, A. S., Wu, X., Zhuang, G., Ngu, H., Kasman, I., Zhang, J., Vernes, J.-M., Jiang, Z., Meng, Y. G., Peale, F. V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3291 · Cited by 445 · cited 16×
“They reported that the ability of 4T1 and other breast cancer cell lines to metastatize to the lungs was highly correlated with G-CSF release by the tumor cells and the resulting mobilization of Ly6G granulocytes, which strongly expressed Bv8/PROK2 (118).”
BackgroundInfluentialSelf-citationDigenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism
Pitteloud, N., Quinton, R., Pearce, S., Raivio, T., Acierno, J., Dwyer, A., Plummer, L., Hughes, V., Seminara, S., Cheng, Y.-Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29884 · Cited by 379
G-CSF: a key regulator of neutrophil production, but that's not all!
Roberts, A. W. (2005) · Growth Factors · doi:10.1080/08977190500055836 · Cited by 335 · cited 1×
“G-CSF is a key regulator of granulopoiesis and is produced by endothelial cells, fibroblasts, and macrophages in response to various inflammatory cytokines (14, 192).”
BackgroundLin, D. C.-H., Bullock, C. M., Ehlert, F. J., Chen, J.-L., Tian, H., & Zhou, Q.-Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202139200 · Cited by 313
Mansour, H. A., Wood, J., Logue, T., Chowdari, K. V., Dayal, M., Kupfer, D. J., Monk, T. H., Devlin, B., & Nimgaonkar, V. L. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00147.x · Cited by 293
Matsumoto, S.-I., Yamazaki, C., Masumoto, K.-H., Nagano, M., Naito, M., Soga, T., Hiyama, H., Matsumoto, M., Takasaki, J., Kamohara, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508881103 · Cited by 281 · cited 6×
“Indeed, all PKR2 knockout mice (but not PKR1 knockout mice) have a dramatic decrease in size and abnormal architecture of the OB receptor-deficient mice (152).”
BackgroundInfluentialLi, M., Bullock, C. M., Knauer, D. J., Ehlert, F. J., & Zhou, Q. Y. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.692 · Cited by 269 · cited 3×
“(136), searching EST databases for homologies to the predicted coding region of Bv8, identified two human sequences, one encoding a protein of 86 amino acids which showed a high degree of homology with VPRA/ MIT1 and the other encoding an 81-amino acid protein highly related to Bv8.”
BackgroundPitteloud, N., Zhang, C., Pignatelli, D., Li, J.-D., Raivio, T., Cole, L. W., Plummer, L., Jacobson-Dickman, E. E., Mellon, P. L., Zhou, Q.-Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707173104 · Cited by 264
PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity
Monnier, C., Dodé, C., Fabre, L., Teixeira, L., Labesse, G., Pin, J.-P., Hardelin, J.-P., & Rondard, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn318 · Cited by 123 · cited 2×
“Computational (132) and genetic (159) analyses indicate that the binding sites for the endogenous peptide ligands reside on the extracellular surface of the receptors in correspondence of the second extracellular loop (EL-II), whereas small non-peptide agonists and recently identified antagonists (9, 82) bind to an al…”
BackgroundPrimary Cilium‐Regulated EG‐VEGF Signaling Facilitates Trophoblast Invasion
Wang, C., Tsai, H., Syu, J., Chen, T., & Su, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25649 · Cited by 52
Cited by
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
“Even though combination therapies of anti-VEGF agents with conventional vascular targets have so far not achieved the expected benefits, several groups are exploring the possibility that combinations with various targets within the tumor microenvironment, including myeloid cell-derived angiogenesis mediators, may lead…”
BackgroundSelf-citationMyeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Biology and therapeutic targeting of vascular endothelial growth factor A
Pérez-Gutiérrez, L., & Ferrara, N. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00631-w · Cited by 484
Self-citationUnveiling the Complex Role of Exosomes in Alzheimer’s Disease
Sun, M., & Chen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466821 · Cited by 39
Zhang, W., Zhang, Y., Hu, N., & Wang, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.990779 · Cited by 12
Metadata
- Authors
- Negri, L., & Ferrara, N.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2018-04-01
- Volume
- 98
- Issue
- 2
- Pages
- 1055-1082
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2789919647
- Cited by
- 93
- References
- 21
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.